{"ticker": {"uuid": "032b3275-87e7-4f5e-9f70-0407ffa83c1d", "symbol": "A", "name": "Agilent Technologies, Inc.", "exchange": "MEX", "country": "MX", "sector": "Healthcare", "industry": "Diagnostics & Research"}, "articles": [{"title": "Agilent Technologies Inc. stock (US00846U1016): Solid Q2 earnings and cautious outlook keep investor", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwgFBVV95cUxPSkkyX0NucWlTNHhKT2QwOUdibElybFJIeEZRNWFoT2VwR2NLcXBGWEM3N2xHNDZ1YnBXRDI0bk5Ca2tXZWJJZHA3ekFrWW5aSl9IMndhYl9pbUxocnI3TExHOFBWVGt0Q1puWnItVGV2RFVWcW90ZnpoZjgyRWU4cWVoMWoyX3Q4OEgtZTRFeHVMaW1qUUxQUTdoZ0M0TkxJNUU2eGF1VVBuTkxmSVh4U0MtWW1mVWh1eVVNLVZZWWJOQQ?oc=5", "source_name": "AD HOC NEWS", "published_at": "2026-06-09T15:10:34+00:00", "published_display": "09 Jun 2026 15:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Agilent to buy contract drug manufacturer Biovectra for $925 million", "summary": "", "url": "https://news.google.com/rss/articles/CBMixwFBVV95cUxPS3hPLUxRV0xfdWhPLU4zZ3ZCZnFFT0pvYVg3Q3pDRjdsV2RUYVM0cjVQVjIwaUNlcURJTUZvTnA4ZlRmVkFWWTBPNXpma24welFGR3JJRGRFWHo2cUJYS2VZX2F1RXZrMUl5WktxcGh0Mk5GWGZwU0R4TEt1TzRELThodWpRQ2RNRVhFbWphT1VBbDQtQVlnMGJDeS1JSTA4dThhUWFtTXRXLWFDNFBreWdMWERqdFBFYlJIWEtmUEhiWTlZcUpv?oc=5", "source_name": "Reuters", "published_at": "2024-07-22T07:00:00+00:00", "published_display": "22 Jul 2024 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Agilent Technologies Inc. stock (US00846U1016): Solid Q2 earnings and cautious outlook keep investor", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwgFBVV95cUxPSkkyX0NucWlTNHhKT2QwOUdibElybFJIeEZRNWFoT2VwR2NLcXBGWEM3N2xHNDZ1YnBXRDI0bk5Ca2tXZWJJZHA3ekFrWW5aSl9IMndhYl9pbUxocnI3TExHOFBWVGt0Q1puWnItVGV2RFVWcW90ZnpoZjgyRWU4cWVoMWoyX3Q4OEgtZTRFeHVMaW1qUUxQUTdoZ0M0TkxJNUU2eGF1VVBuTkxmSVh4U0MtWW1mVWh1eVVNLVZZWWJOQQ?oc=5", "source_name": "AD HOC NEWS", "published_at": "2026-06-09T15:10:34+00:00", "published_display": "09 Jun 2026 15:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Agilent to buy contract drug manufacturer Biovectra for $925 million", "summary": "", "url": "https://news.google.com/rss/articles/CBMixwFBVV95cUxPS3hPLUxRV0xfdWhPLU4zZ3ZCZnFFT0pvYVg3Q3pDRjdsV2RUYVM0cjVQVjIwaUNlcURJTUZvTnA4ZlRmVkFWWTBPNXpma24welFGR3JJRGRFWHo2cUJYS2VZX2F1RXZrMUl5WktxcGh0Mk5GWGZwU0R4TEt1TzRELThodWpRQ2RNRVhFbWphT1VBbDQtQVlnMGJDeS1JSTA4dThhUWFtTXRXLWFDNFBreWdMWERqdFBFYlJIWEtmUEhiWTlZcUpv?oc=5", "source_name": "Reuters", "published_at": "2024-07-22T07:00:00+00:00", "published_display": "22 Jul 2024 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 88, "total_relevant": 2, "sentiment_summary": {"positive": 1, "negative": 0, "neutral": 1, "score": 60, "total": 2, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "deals", "primary_label": "Deals and strategy", "confidence": 62, "events": [{"event": "deals", "label": "Deals and strategy", "weight": 0.9, "count": 1}, {"event": "earnings", "label": "Earnings", "weight": 0.55, "count": 1}], "positive_events": 1, "negative_events": 0}, "market_context": {"has_market_context": true, "latest_close": 2350.0, "latest_week": "2026-06-19", "one_week_move": 0.0, "four_week_move": 20.2, "twelve_week_move": 11.9, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": 0.464086, "market_dynamics_buy_signal": false, "relative_strength": -6.124797, "fair_value_gap": -6.8, "fair_value_label": "Near fair-value range", "fair_value_tone": "neutral", "expectation_direction": "negative", "expectation_probability": 12.6722, "reaction_label": "Price digesting", "reaction_tone": "neutral", "market_sentence": "+0.0% over one week, +20.2% over four weeks, trend inactive, and near fair-value range."}, "interpretation": {"label": "Balanced read", "tone": "neutral", "classification": "balanced", "summary": "News tone and price action are not far from neutral.", "confidence": 54, "badges": [], "opportunities": [], "risks": [], "event_label": "Deals and strategy", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "AD HOC NEWS", "count": 1}, {"label": "Reuters", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 2}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Earnings", "count": 1}, {"label": "Deals and strategy", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "60/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Balanced read", "tone": "neutral", "text": "News tone and price action are not far from neutral."}, {"label": "Primary event", "value": "Deals and strategy", "tone": "neutral", "text": "62/100 classification confidence."}, {"label": "Company focus", "value": "2", "tone": "neutral", "text": "directly relevant articles"}, {"label": "Source quality", "value": "1", "tone": "positive", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "+0.0% over one week, +20.2% over four weeks, trend inactive, and near fair-value range."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "Agilent Technologies Inc. stock (US00846U1016): Solid Q2 earnings and cautious outlook keep investor"}], "updated_at": "2026-06-22T21:32:39.669746+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}